Literature DB >> 28192104

Practical Use of Pharmacotherapy for Obesity.

Leon I Igel1, Rekha B Kumar2, Katherine H Saunders2, Louis J Aronne2.   

Abstract

Obesity management requires a multidisciplinary approach, as there are many factors that contribute to the development of obesity, as well as the preservation of excess weight once it has been gained. Diet, exercise, and behavior modification are key components of treatment. In addition to lifestyle changes, weight gain secondary to medications is an important modifiable risk factor. Even after appropriate lifestyle modification, and medication adjustments (where possible) to avoid agents that can contribute to weight gain, many patients are still unable to achieve clinically meaningful weight loss. Pharmacotherapy for obesity management can fill an important role for these patients. This article will review medications that can lead to weight gain and potential alternatives, currently approved anti-obesity medications and best practices to individualize the selection process, and the use of testosterone in men with hypogonadism and obesity.
Copyright © 2017 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Obesity; Pharmacotherapy; Testosterone; Weight Management

Mesh:

Substances:

Year:  2017        PMID: 28192104     DOI: 10.1053/j.gastro.2016.12.049

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  12 in total

Review 1.  CRISPR/Cas9, the Powerful New Genome-Editing Tool for Putative Therapeutics in Obesity.

Authors:  María José Franco-Tormo; Mireille Salas-Crisostomo; Nuno Barbosa Rocha; Henning Budde; Sérgio Machado; Eric Murillo-Rodríguez
Journal:  J Mol Neurosci       Date:  2018-05-07       Impact factor: 3.444

2.  Characterization of on-target adverse events caused by TRK inhibitor therapy.

Authors:  D Liu; J Flory; A Lin; M Offin; C J Falcon; Y R Murciano-Goroff; E Rosen; R Guo; E Basu; B T Li; J J Harding; G Iyer; K Jhaveri; M M Gounder; N N Shukla; S S Roberts; J Glade-Bender; L Kaplanis; A Schram; D M Hyman; A Drilon
Journal:  Ann Oncol       Date:  2020-05-15       Impact factor: 32.976

Review 3.  Devices and Endoscopic Bariatric Therapies for Obesity.

Authors:  Katherine H Saunders; Leon I Igel; Monica Saumoy; Reem Z Sharaiha; Louis J Aronne
Journal:  Curr Obes Rep       Date:  2018-06

Review 4.  Why Weight? An Analytic Review of Obesity Management, Diabetes Prevention, and Cardiovascular Risk Reduction.

Authors:  L I Igel; K H Saunders; J J Fins
Journal:  Curr Atheroscler Rep       Date:  2018-05-21       Impact factor: 5.113

Review 5.  Incorporating Weight Loss Medications Into Hepatology Practice for Nonalcoholic Steatohepatitis.

Authors:  Albert Do; Eric J Kuszewski; Karl A Langberg; Wajahat Z Mehal
Journal:  Hepatology       Date:  2019-10       Impact factor: 17.425

Review 6.  Precision Medicine and Obesity.

Authors:  Daniel Sacoto; Maria Daniela Hurtado; Andres Acosta
Journal:  Handb Exp Pharmacol       Date:  2022

7.  Selection of Antiobesity Medications Based on Phenotypes Enhances Weight Loss: A Pragmatic Trial in an Obesity Clinic.

Authors:  Andres Acosta; Michael Camilleri; Barham Abu Dayyeh; Gerardo Calderon; Daniel Gonzalez; Alison McRae; William Rossini; Sneha Singh; Duane Burton; Matthew M Clark
Journal:  Obesity (Silver Spring)       Date:  2021-04       Impact factor: 5.002

Review 8.  Endoscopy training in Korea.

Authors:  Joon Sung Kim; Byung-Wook Kim
Journal:  Korean J Intern Med       Date:  2019-02-25       Impact factor: 2.884

9.  Training in Bariatric and Metabolic Endoscopic Therapies.

Authors:  Pichamol Jirapinyo; Christopher C Thompson
Journal:  Clin Endosc       Date:  2018-09-30

10.  Are people with metabolically healthy obesity really healthy? A prospective cohort study of 381,363 UK Biobank participants.

Authors:  Ziyi Zhou; John Macpherson; Stuart R Gray; Jason M R Gill; Paul Welsh; Carlos Celis-Morales; Naveed Sattar; Jill P Pell; Frederick K Ho
Journal:  Diabetologia       Date:  2021-06-10       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.